Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000236

EVP, Chief Technical Ops. Off. sold 2,500 shares at $434.58 ($1,086,450)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-17 Sale : show line 1 in the form 10b5-1 −2,500 $434.58 $1,086,450 16,852 D
Open-market sales · 2,500 sh · avg $434.58 · $1,086,450
Loading xslF345X05/wk-form4_1763586372.xml…